title: The use of lanreotide in the management of lymphorrhea after an aortic valve replacement.
abstract: Lymphorrhea is a rare but potentially serious complication following various surgical procedures. Uncontrolled lymph drainage may lead to infection and prolonged hospital stay. Currently, there is no standard effective treatment. Early management usually involves bed rest, drainage and pressure dressings. These methods are associated with prolonged recovery and high recurrence rates. We report a case of lymphorrhea from the groin wound after an aortic valve replacement. The patient presented with significant lymph drainage from the postoperative inguinal wound. Lymphorrhea was successfully treated with a long-acting somatostatin analogue, lanreotide. No recurrence was observed after 1 and 6 months of patient follow-up. This case report demonstrates the successful use of lanreotide in the control of lymphorrhea following groin dissection for vascular access.
authors: Service de Chirurgie Viscérale et Vasculaire, CHU Ambroise Paré, Mons, Belgium. jean.lemaitre@hap.be
authors: Jean
authors: J
authors: Lemaitre
authors: Bernard
authors: B
authors: Segers
authors: Eric
authors: E
authors: Lebrun
mesh_terms: D000368:Aged; D001021:Aortic Valve / Q000601:surgery*; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects*; D006801:Humans; D008206:Lymphatic Diseases / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D010456:Peptides, Cyclic / Q000627:therapeutic use*; D011677:Punctures; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin